JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EAGLE, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by EAGLE, H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 64, Issue 2, 164-189, 1938
Copyright © 1938 by American Society for Pharmacology and Experimental Therapeutics


ON THE SPIROCHETICIDAL ACTION OF THE ARSPHENAMINES ON SPIROCHETA PALLIDA IN VITRO

HARRY EAGLE 1

1 From the Syphilis Division of the Department of Medicine, Johns Hopkins Medical School, Baltimore, and the United States Public Health Service, Washington

Arsphenamine, neoarsphenamine, silver arsphenamine and "arsenoxide" (m-amino-p-hydroxyphenylarsenoxide) have been found to immobilize S. pallida in emulsions of rabbit chancres in vitro, and to render them non-infectious for rabbits. Under the experimental conditions here used, these arsenicals are therefore probably spirocheticidal.

The rate at which the immobilization proceeds and the minimal effective concentrations of arsenical depend on numerous variables, some of which are discussed in the text. Thus, activity increases with increasing temperature, and is markedly inhibited by the addition of tissue or tissue derivatives, perhaps because these combine with the arsenical. Inhibition by serum is relatively slight. The action is not demonstrably affected by the anaerobiasis attained in the Brown anaerobe jar.

Under appropriate experimental conditions, arsphenamine, silver arsphenamine, and neoarsphenamine have a definite spirocheticidal effect in vitro within eight hours in as high as a 1:250,000 dilution; and "arsenoxide" is antispirochetal in dilutions of at least one million. It is of interest that these concentrations are of the same order of magnitude as those attained in vivo after the therapeutic administration of these drugs. The extent to which oxidation products of the arsphenamines are responsible for the in vitro effects here described is clearly of primary importance, and is now being studied.

Submitted on February 28, 1938







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1938 by the American Society for Pharmacology and Experimental Therapeutics.